FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Downgrades Insulet to Market Perform From Outperform, Adjusts PT to $145 From $247

By

Insulet (PODD) has an average rating of overweight and mean price target of $185.43, according to analysts polled by FactSet.

What else is happening in Research?